JWH-073 (methanol solution)

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 561200

CAS#: 208987-48-8

Description: JWH-073 is a synthetic cannabinoid, is an analgesic chemical from the naphthoylindole family that acts as a partial agonist at both the CB1 and CB2 cannabinoid receptors. Note: This product is supplied in methanol solution. JWH-073 is discontinued (DEA controlled substance).

Chemical Structure

JWH-073 (methanol solution)
CAS# 208987-48-8

Theoretical Analysis

MedKoo Cat#: 561200
Name: JWH-073 (methanol solution)
CAS#: 208987-48-8
Chemical Formula: C23H21NO
Exact Mass: 327.1623
Molecular Weight: 327.427
Elemental Analysis: C, 84.37; H, 6.46; N, 4.28; O, 4.89

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Related CAS #: 208987-48-8  

Synonym: JWH-073; JWH073; JWH 073

IUPAC/Chemical Name: (1-Butyl-1H-indol-3-yl)-1-naphthalenyl-methanone


InChi Code: InChI=1S/C16H24ClN.ClH/c1-12(2)11-15(16-5-3-4-10-18-16)13-6-8-14(17)9-7-13;/h6-9,12,15-16,18H,3-5,10-11H2,1-2H3;1H/t15-,16-;/m1./s1

SMILES Code: CC(C)C[C@@H]([C@@H]1NCCCC1)C2=CC=C(Cl)C=C2.[H]Cl

Appearance: A solution in methanol

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

Preparing Stock Solutions

The following data is based on the product molecular weight 327.427 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.


Dilution Calculator

Calculate the dilution required to prepare a stock solution.

1: Stout SM, Cimino NM. Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review. Drug Metab Rev. 2014 Feb;46(1):86-95. doi: 10.3109/03602532.2013.849268. Epub 2013 Oct 25. Review. PubMed PMID: 24160757.

2: Presley BC, Jansen-Varnum SA, Logan BK. Analysis of Synthetic Cannabinoids in Botanical Material: A Review of Analytical Methods and Findings. Forensic Sci Rev. 2013 Mar;25(1-2):27-46. Review. PubMed PMID: 26226849.

3: Burillo-Putze G, Díaz BC, Pazos JL, Mas PM, Miró O, Puiguriguer J, Dargan P. [Emergent drugs (I): smart drugs]. An Sist Sanit Navar. 2011 May-Aug;34(2):263-74. Review. Spanish. PubMed PMID: 21904408.

4: Brents LK, Prather PL. The K2/Spice phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products. Drug Metab Rev. 2014 Feb;46(1):72-85. doi: 10.3109/03602532.2013.839700. Epub 2013 Sep 24. Review. PubMed PMID: 24063277; PubMed Central PMCID: PMC4100246.

5: Papanti D, Schifano F, Botteon G, Bertossi F, Mannix J, Vidoni D, Impagnatiello M, Pascolo-Fabrici E, Bonavigo T. "Spiceophrenia": a systematic overview of "spice"-related psychopathological issues and a case report. Hum Psychopharmacol. 2013 Jul;28(4):379-89. doi: 10.1002/hup.2312. Review. PubMed PMID: 23881886.

6: Järbe TUC, Raghav JG. Tripping with Synthetic Cannabinoids ("Spice"): Anecdotal and Experimental Observations in Animals and Man. Curr Top Behav Neurosci. 2017;32:263-281. doi: 10.1007/7854_2016_16. Review. PubMed PMID: 27753006.